TGF-β and cancer: Is Smad3 a repressor of hTERT gene?

被引：0
作者：
He Li
Dakang Xu
Ban-Hock Toh
Jun-Ping Liu
机构：
[1] Molecular Signaling Laboratory,Department of Immunology
[2] Monash University,undefined
来源：
Cell Research | 2006年 / 16卷
关键词：
telomerase; TERT; gene expression; Smad3; TGF-β; cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Transforming growth factor β (TGF-β) carries out tumor suppressor activity in epithelial and lymphoid cells, whereas telomerase is required for most cancers. Although the molecular mechanisms by which TGF-β acts as a tumor suppressor are yet to be fully established, a link between TGFb and its tumor suppressor activity by telomerase has been suggested. Recently, we have noted a novel mode of action for TGF-β through which human telomerase reverse transcriptase (hTERT) gene is repressed in immortal and neoplastic cells, confirming that one of the mechanisms underlying TGF-β suppression of tumor growth may be through inhibiting hTERT gene transcription. Moreover, the inhibition of hTERT gene by TGF-β suggests a cis action of the TGF-β signaling molecule Smad3 on hTERT promoter directly. This article examines our current understanding and investigation of TGF-β regulation of telomerase activity, and presents a model in which Smad3 participates in regulating hTERT gene transcription by acting as a repressor directly. Engineering the interface between Smad3 and hTERT gene may lead to a new strategy to inhibit telomerase activity in cancer.
引用
收藏
页码：169 / 173
页数：4
相关论文
共 113 条
[31]  
Nakayama J(2004)On the road to immortality: hTERT upregulation in cancer cells FEBS Lett 564 9-13
[32]  
Tahara H(1999)Direct activation of TERT transcription by c-MYC Nat Genet 21 220-4
[33]  
Tahara E(2001)Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells Proc Natl Acad Sci U S A 98 3826-31
[34]  
Vaziri H(2002)Variant forms of upstream stimulatory factors (USFs) control the promoter activity of hTERT, the human gene encoding the catalytic subunit of telomerase FEBS Lett 520 40-6
[35]  
Benchimol S(2004)Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA Cancer Res 64 4833-40
[36]  
Wen J(2004)Recent advances in the development of peptide nucleic acid as a gene-targeted drug Expert Opin Biol Ther 4 337-48
[37]  
Cong YS(2005)Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics—current status and future prospects Eur J Cancer 41 971-9
[38]  
Bacchetti S(2005)Hormones and growth factors regulate telomerase activity in ageing and cancer Mol Cell Endocrinol 240 11-22
[39]  
Counter CM(2004)Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element Mol Cell Biol 24 2546-59
[40]  
Hahn WC(1999)Studies of the molecular mechanisms in the regulation of telomerase activity FASEB J 13 2091-104
12345678910